REPL
Replimune Group Inc
NASDAQ: REPL · HEALTHCARE · BIOTECHNOLOGY
$2.38
-7.39% today
Updated 2026-04-29
Market cap
$212.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.44
Dividend yield
—
52W range
$2 – $13
Volume
5.4M
Replimune Group Inc (REPL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-11.4%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+2.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.1%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+3.8%
2025-11-11
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-03 | $-0.77 | -0.8% | $6.98 | $7.00 | +0.4% |
| 2025-11-11 | $-0.90 | -7.1% | $8.71 | $9.04 | +3.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.76 | $-0.77 | -0.8% | — | — |
| 2025-09-30 | $-0.84 | $-0.90 | -7.1% | — | — |
| 2025-06-30 | $-0.80 | $-0.95 | -18.7% | — | — |
| 2025-03-31 | $-0.69 | $-0.82 | -18.8% | $1.47M | -63.6% |
| 2024-12-31 | $-0.72 | $-0.79 | -9.7% | — | — |
| 2024-09-30 | $-0.74 | $-0.68 | +8.1% | — | — |
| 2024-06-30 | $-0.85 | $-0.78 | +8.2% | — | — |
| 2024-03-31 | $-0.79 | $-0.82 | -3.8% | $4.04M | — |
| 2023-12-31 | $-0.93 | $-0.77 | +17.2% | — | — |
| 2023-09-30 | $-0.86 | $-0.90 | -4.7% | — | — |
| 2023-06-30 | $-0.84 | $-0.75 | +10.7% | — | — |
| 2023-03-31 | $-0.67 | $-0.74 | -10.4% | — | — |
Frequently asked questions
Has Replimune Group Inc beaten earnings estimates?
Replimune Group Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -11.4% over the last 4 quarters.
How does REPL stock react to earnings?
REPL stock has moved an average of +2.1% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.